期刊文献+

甘精胰岛素皮下注射药液外漏的研究

Outside the saccharine insulin hypodermic injection solution leaks research
原文传递
导出
摘要 目的:了解改良皮下注射法用于甘精胰岛素注射后药液外漏的研究。方法:选择使用甘精胰岛素皮下注射治疗的糖尿病患者106例,以患者左上臂为观察组(采用改良皮下注射法),右上臂为对照组(采用常规皮下注射法),观察并记录左右上臂各注射一针后药液外漏的情况。结果:观察组和对照组各106例,注射后药液外漏发生率分别为13.1%和31.1%,两者比较药液外漏发生率有统计学意义(P〈O.05)。结论:采用改良皮下注射法并留针10秒钟后拔针的方法,可以降低甘精胰岛素注射后药液外漏发生率,提高用药剂量的准确性,减少患者的住院天数,降低住院费用。 Objective:To evaluate the study of improved laypodermic injection in drug leakage reaction of insulin Glargine injic- tiong. Methods:Select 106 diabetes mellitus patients who is receiving hypodermic insulin Glargine injiction and set their left uppar arms as obervation group(using improved hypodermic injection),while the right the uppar arms as control group(using normal hy- podermic injection). Measure and record the leakage reaction of every single needle point on each left and right arm. Results: Occurrence of drug leakage rates 13.1 % in the obervation group while 31.1% in the control group. The result has statistical significance (P%0.05). Conclusion: Improved hypodermic injection and retaining the needle for 10 seconds can reduc occurrence of drug leakage, improv dosage accuracy,decrease hospital times and cost.
作者 余剑敏
出处 《按摩与康复医学》 2011年第12期23-24,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 皮下注射 药液外漏 甘精胰岛素 Hypodermic injection Drug Leakage reaction Glargine
  • 相关文献

参考文献3

  • 1杨昱,王昆,刘超.糖尿病基础胰岛素治疗[J].中国实用内科杂志,2010,30(10):939-941. 被引量:20
  • 2刘慧琴.应用胰岛素不同给药途径的护理.现代护理实践杂志,2009,100(8):17-18.
  • 3李晓寒,尚少梅.《基础护理学》第4版(M).人民卫生出版社,2007:8.

二级参考文献13

  • 1Porcellati F, Rossetti P, Busciantella NR, et al. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes[J]. Diabetes Care, 2007, ( 30 ) :2447 - 2452.
  • 2Miles HL, Acerini CL. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus [ J ]. Pediatr Drugs,2008,10 (3) :163 -176.
  • 3Crasto W,Jarvis J, Khunti K, et al. New insulins and new insulin regimens:a review of their role in improving glycaemic control in patients with diabetes [ J ]. Postgrad Med J,2009,85:257 - 267.
  • 4Rosenstock J, Davies M, Home PD, et al. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulinnaive people with type 2 diabetes [ J ]. Diabetologia, 2008 ( 51 ) : 408 -416.
  • 5Rossetti P, Pampanelli S, Fanelli C,et al. Intesive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime[J]. Diabetes care,2003,26:1490 - 1496.
  • 6Peterson GE. Inter mediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir [ J ]. Curt Med Res Opin,2006,22 (12) :2613 - 2619.
  • 7Riddle MC, Rosenstock J, Gerieh J, et al. The treat-to-target trial, randomized addition of glargine or human NPH insulin ro oral therapy of type 2 diabetic patients [ J ]. Diabetes Care, 2003 (26) :3080-3086.
  • 8Vague P,Selam JL, Skeie S, et al. Insulin determir is associated with more predictable glycemJc control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart [ J ]. Diabetes Care,2003 (26) :590-596.
  • 9Johnson CK. When a unit of insulin is not a unit:Determir dosing and insulin cost in type 2 diabetes mellitus [ J ]. Insulin, 2009,4: 87 - 93.
  • 10Soliman AT, Omar M, Rizk MM, et al.Glycaemic control with modified intensive insulin injuctions (MII) using insulin pens and premixed insulin in children with type 1 diabetes:a randomized controlled trial [ J 1. J Trop Pediatr, 2006,52:276 - 281.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部